(-)-Ibuprofenamide
≥98%
- Product Code: 61664
CAS:
121839-78-9
Molecular Weight: | 205.3 g./mol | Molecular Formula: | C₁₃H₁₉NO |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
(-)-Ibuprofenamide is primarily utilized in pharmaceutical research as a chiral intermediate for the synthesis of enantiomerically pure ibuprofen, a widely used nonsteroidal anti-inflammatory drug (NSAID). Its application is crucial in developing formulations with improved efficacy and reduced side effects, as the (-)-enantiomer of ibuprofen is known to exhibit higher biological activity compared to its (+)-counterpart. Additionally, it serves as a valuable compound in studying the stereoselective metabolism and pharmacokinetics of ibuprofen, aiding in the design of more targeted and efficient therapeutic agents.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.005 | 10-20 days | ฿9,000.00 |
+
-
|
(-)-Ibuprofenamide
(-)-Ibuprofenamide is primarily utilized in pharmaceutical research as a chiral intermediate for the synthesis of enantiomerically pure ibuprofen, a widely used nonsteroidal anti-inflammatory drug (NSAID). Its application is crucial in developing formulations with improved efficacy and reduced side effects, as the (-)-enantiomer of ibuprofen is known to exhibit higher biological activity compared to its (+)-counterpart. Additionally, it serves as a valuable compound in studying the stereoselective metabolism and pharmacokinetics of ibuprofen, aiding in the design of more targeted and efficient therapeutic agents.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :